Navigation Links
Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
Date:3/26/2013

nations) and negative (e.g., flat affect) symptoms of schizophrenia.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-Looking Statements
This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, Omeros' expectations regarding the potential qualities of OMS824; that it will request orphan drug and Fast Track designations for OMS824; that it will advance OMS824 into a Phase 2 clinical program; that it will submit an NDA and MAA for OMS302 this year; that it will advance its MASP-2 and PDE7 programs into the clinic in the coming months; and that Omeros may have capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
2. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
3. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
4. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
5. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
6. Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference
7. Omeros is Not Aware of Any Justification for Share Price Movement
8. Omeros Corporation Reports Third Quarter 2012 Financial Results
9. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
10. Omeros Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial
11. Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 According to a ... by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... reach $2.64 Billion by 2020, growing at a CAGR ... Browse 119 market T ables ...
(Date:7/1/2015)... July 1, 2015 Prismic Pharmaceuticals, Inc., a ... medical foods, today announced the election of Joseph ... to its Board of Directors. Commenting on ... Peter Moriarty , Chairman and CEO of Prismic, stated, ... Martin Simonetti have accepted our invitation to ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics ... manufacturer and marketer of rehabilitation and physical therapy ... $4,025,000 private placement financing led by affiliates of ... equity investor focused on the healthcare industry. The ... organic growth and pursue potential strategic acquisitions.  ...
Breaking Medicine Technology:Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 3Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 4Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... , HELSINKI, Dec. 14 Cancer patients in Finland ... of RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: ... the Nordic region. Clinicians at Docrates Clinic in Helsinki are ... patients with multiple brain metastases and cancers of the abdomen ...
... , WALTHAM, Mass., Dec. 14 According to ... market intelligence, increased use of safety devices for small-bore connectors ... of the enteral feeding device markets in both the US ... Enteral Feeding Devices 2010 report finds that the giving ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
(Date:7/1/2015)... VA (PRWEB) , ... July 01, 2015 , ... Dr. ... on Monday, July 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive ... where diet and exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis to ...
(Date:7/1/2015)... ... 2015 , ... Summer recess has a whole new meaning. Thanks to social ... plastic surgery when they’re looking for a boost in self-esteem. According to the American ... on patients ages 19 and younger in 2012, an increase from previous years. ...
(Date:7/1/2015)... Springs, Colorado) , ... - (PRWEB) July 01, 2015 , ... ... hosting a nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of ... Keys, a highly decorated soldier and recipient of the Bronze Star Medal, died during ...
(Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor ... at USF earning a Master’s degree in Microbiology. He graduated from the University of ... Dental Association, the Florida Dental Association and the Academy of General Dentistry. Dr. Williams ...
(Date:7/1/2015)... ... 01, 2015 , ... Franklin University, one of the leading educators of working ... been named Dean of the College of Health & Public Administration . ... the vision and mission of Franklin University via curriculum planning, course scheduling, faculty staffing ...
Breaking Medicine News(10 mins):Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Franklin University Appoints Dean of College of Health & Public Administration 2
... April 16 marks one year,since the most ... the,anniversary of the Virginia Tech shootings nears, survivors, ... of,Blacksburg, Virginia, may re-experience many of the same ... of traumatic events can reactivate thoughts and,feelings from ...
... Thirty Grand-Prize Winners Will "Laugh for a Week and ... LifeScan, a Johnson &,Johnson company and the maker ... announced an online sweepstakes that will offer,an opportunity for ... free,this summer. The OneTouch(R) Laugh & Learn Sweepstakes, which ...
... thought Alzheimer,s, I thought gray hair, says Chicago father of ... April 11 (HealthDay News) -- Construction foreman Jim Mueller was ... He,d forget things: his schedule, his equipment, where he was, ... his daughters and his wife. But nothing prepared the Mueller ...
... ablation in the treatment of colorectal liver metastases is ... to a recent study conducted by researchers at Charit, ... ablation (RFA) has become a widely used treatment option ... from some primary tumors, if surgery is not an ...
... for EMRs Best Meeting Medicolegal Requirements, BOSTON, ... records systems remain in active development through the,continuing ... Currently, though, the burden of proof (and risk) ... on the purchaser.,Furthermore, there are few resources for ...
... Draeger was awarded with the,2007 Frost & Sullivan ... honor the manufacturer which best fulfills the customers ... ease of use,technical features, comfort, and design., ... is given based on two studies from Frost ...
Cached Medicine News:Health News:For Virginia Tech Community, Anxiety and Sadness May Increase on Anniversary of School Shootings 2Health News:OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes 2Health News:OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes 3Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 2Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 3Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 4Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 5Health News:Medical Records Institute (MRI) Develops Initiative for EMRs Supporting Medicolegal Requirements 2Health News:Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: